Tubulis GmbH products

Our P5 conjugation technology allows to rapidly generate ultra-stable ADCs with unprecedented linker stability and chemical flexibility, providing us with the opportunity to develop truly differentiated ADCs.

Improving patient benefit by increasing the therapeutic window